Abstract
The goal of this study was to investigate the association between the polymorphic loci of genes IL1B (rs16944), IL1RN (rs4251961), IL6 (rs1800795, rs1800796, rs1554606), IL8 (rs4073), IL10 (rs1800896), and TNFA (rs1800629) and breast cancer in women. The DNA samples of 521 women with breast cancer and 267 women without oncological pathology were studied. The study showed that age, concomitant chronic morbidity, and polymorphism of the IL6 gene are risk factors in postmenopausal women. Allele –572C (OR = 5.68; 95% CI = [2.70–11.97], pcor < 0.001), and haplotype rs1800796[C]–rs1800795[G]–rs1554606[G] (OR = 5.31, 95% CI = [1.87 – 15.10], pcor = 0.002) of the IL6 gene were associated with breast cancer. No association of loci in IL1B (rs16944), IL1RN (rs4251961), IL8 (rs4073), IL10 (rs1800896), or TNFA (rs1800629) was associated with the risk of breast cancer. The obtained data indicate that the –572C allele of the IL6 gene is associated with susceptibility in postmenopausal women to breast cancer. Our results can be useful for an understanding of the molecular mechanisms of breast cancer.
Similar content being viewed by others
REFERENCES
Baranov, V.S., Glotov, O.S., and Baranova, E.V., New genetic and epigenetic approaches in gerontology, Adv. Gerontol., 2014, vol. 4, no. 4, pp. 238–246.
Bershtein, L.M., Epidemic “non-steroidal triad” (obesity, diabetes, metabolic syndrome) and breast cancer, Zlokach. Opukholi, 2018, no. 3s1, pp. 5–8. https://doi.org/10.18027/2224-5057-2018-8-3s1-5-8
Gromova, A.Yu. and Simbirtsev, A.S., Polymorphism of human IL-1 family genes, Tsitokiny Vospalenie, 2005, vol. 4, no. 2, pp. 3–12.
Kozlov, V.A., Methylation of cell DNA and pathology of the organism, Med. Immunol., 2008, vol. 10, nos. 4–5, pp. 307–318.
Les’ko, K.A., Byakhov, M.Yu., Abduraimov, A.B., et al., Choice of a strategy for breast cancer screening in women of older age groups, Zlokach. Opukholi, 2017, vol. 3, no. 3, pp. 5–12.
Malygina, N.A., Cell aging and age-related diseases, Klin. Gerontol., 2014, nos. 3–4, pp. 30–34.
Mustafina, O.E., Pauk, V.V., Mustafina, R.S., et al., Polymorphism of cytokine genes and human longevity, Adv. Gerontol., 2010, vol. 1, no. 2, pp. 159–165.
Nazarova, E.L., Dem’yanova, V.T., Shardakov, V.I., et al., Associations of polymorphism of a number of innate immunity genes with the risk of chronic lymphoproliferative diseases, Gematol. Transfusiol., 2016, vol. 61, no. 4, pp. 183–189.
Rubanovich, A.V. and Khromov-Borisov, N.N., Theoretical analysis of the predictability indices of the binary genetic tests, Russ. J. Genet. Appl. Res., 2014, vol. 4, no. 2, pp. 146–158.
Rydlovskaya, A.V. and Simbirtsev, A.S., Functional polymorphism of TNFA gene and pathology, Tsitokiny Vospalenie, 2005, vol. 4, no. 3, pp. 4–10.
Baune, B.T., Dannlowski, U., Domschke, K., et al., The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression, Biol. Psychiatry, 2010, vol. 67, no. 6, pp. 543–549. https://doi.org/10.1016/j.biopsych.2009.11.004
Becker, K.J., Dankwa, D., Lee, R., et al., Stroke, IL-1ra, IL1RN, infection and outcome, Neurocrit. Care, 2014, vol. 21, no. 1, pp. 140–146.
Dandrea, M., Donadelli, M., Costanzo, C., et al., MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines, Nucleic Acids Res., 2009, vol. 37, no. 20, pp. 6681–6690. https://doi.org/10.1093/nar/gkp723
DeMichele, A., Martin, A.M., Mick, R., et al., Interleukin-6 and the IL-6 (–174) C/G polymorphism in breast pathologies and in HIV-infected patients, Cancer Res., 2003, vol. 63, no. 22, pp. 8051–8056.
DeMichele, A., Gray, R., Horn, M., et al., Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer, Cancer Res., 2009, vol. 69, no. 10, pp. 4184–4191. https://doi.org/10.1158/0008-5472.CAN-08-2989
Grivennikov, S.I., Greten, F.R., and Karin, M., Immunity, inflammation, and cancer, Cell, 2010, vol. 140, no. 6, pp. 883–899. https://doi.org/10.1016/j.cell.2010.01.025
Gyamfi, J., Eom, M., Koo, J.S., and Choi, J., Multifaceted roles of interleukin-6 in adipocyte–breast cancer cell interaction, Transl. Oncol., 2018, vol. 11, no. 2, pp. 275–285. https://doi.org/10.1016/j.tranon.2017.12.009
Hefler, L.A., Grimm, C., Lantzsch, T., et al., Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women, Clin. Cancer Res., 2005, vol. 11, no. 16, pp. 5718–5721.
Iacopetta, B., Grieu, F., and Joseph, D., The –174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype, Br. J. Cancer, 2004, vol. 90, no. 2, pp. 419–422.
Konwar, C., Del Gobbo, G.F., Terry, J., and Robinson, W.P., Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis, BMC Med. Genet., 2019, vol. 20, no. 1, p. 36. https://doi.org/10.1186/s12881-019-0768-0
Kozłowski, L., Zakrzewska, I., Tokajuk, P., and Wojtukiewicz, M.Z., Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients, Rocz. Akad. Med. Bialymstoku, 2003, vol. 48, pp. 82–84.
Leonardi, G.C., Accardi, G., Monastero, R., et al., Ageing: from inflammation to cancer, Immun. Ageing, 2018, vol. 15, p. 1. https://doi.org/10.1186/s12979-017-0112-5
Liu, Y., Berthier-Schaad, Y., Fallin, M.D., et al., IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysiscohort, J. Am. Soc. Nephrol., 2006, vol. 17, no. 3, pp. 863–870.
Maggio, M., Guralnik, J.M., Longo, D.L., and Ferrucci, L., Interleukin-6 in aging and chronic disease: a magnificent pathway, J. Gerontol., Ser. A, 2006, vol. 61, no. 6, pp. 575–584.
Markkula, A., Simonsson, M., Ingvar, C., et al., IL6 genotype, tumor ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort, BMC Cancer, 2014, vol. 14, p. 759. https://doi.org/10.1186/1471-2407-14-759
Masjedi, A., Hashemi, V., Hojjat-Farsangi, M., et al., The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer, Biomed. Pharmacother., 2018, vol. 10, pp. 1415–1424. https://doi.org/10.1016/j.biopha.2018.09.177
Naugler, W.E. and Karin, M., The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer, Trends Mol. Med., 2008, vol. 14, no. 3, pp. 109–119. https://doi.org/10.1016/j.molmed.2007.12.007
Peng, X., Shi, J., Sun, W., et al., Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis, Oncotarget, 2018, vol. 9, no. 15, pp. 12 351–12 364. https://doi.org/10.18632/oncotarget.24033
Qu, X., Tang, Y., and Hua, S., Immunological approaches towards cancer and inflammation: a cross talk, Front. Immunol., 2018, vol. 9, p. 563. https://doi.org/10.3389/fimmu.2018.00563
Roodposhti, S.Z., Motalleb, G., and Nikokar, I., Rs4073 single nucleotide polymorphism of interleukin-8 (CXCL8/IL-8) and susceptibility to pulmonary tuberculosis in Gilan, Northern Iran, Gene Rep., 2018, vol. 11, pp. 127–130. https://doi.org/10.1016/j.genrep.2018.03.004
Shadrina, A., Voronina, E., Smetanina, M., et al., Polymorphisms in inflammation-related genes and the risk of primary varicose veins in ethnic Russians, Immunol. Res., 2018, vol. 66, no. 1, pp. 141–150. https://doi.org/10.1007/s12026-017-8981-4
Slattery, M.L., Curtin, K., Baumgartner, R., et al., IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States, Cancer Epidemiol., Biomarkers Prev., 2007, vol. 16, no. 4, pp. 747–755.
Slattery, M.L., Curtin, K., Sweeney, C., et al., Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk, Obesity, 2008, vol. 16, no. 2, pp. 339–347. https://doi.org/10.1038/oby.2007.44
Slattery, M.L., Wolff, R.K., Herrick, J., et al., Tumor markers and rectal cancer: support for an inflammation-related pathway, Int. J. Cancer, 2009, vol. 125, no. 7, pp. 1698–1704. https://doi.org/10.1002/ijc.24467
Syed, B.M., Green, A.R., Paish, E.C., et al., Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts, Br. J. Cancer, 2013, vol. 108, no. 5, pp. 1042–1051. https://doi.org/10.1038/bjc.2012.601
Wang, H. and Yang, X., Association between serum cytokines and progression of breast cancer in Chinese population, Medicine (Baltimore), 2017, vol. 96, no. 49, p. e8840. https://doi.org/10.1097/MD.0000000000008840
Zhu, R.M., Lin, W., Zhang, W., et al., Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival, PLoS One, 2017, vol. 12, no. 6, p. e0178 850. https://doi.org/10.1371/journal.pone.0178850
Funding
This work was carried out within the framework of project VI.59.1.1 of the Program of Fundamental Scientific Research of the Siberian Branch of the Russian Academy of Sciences (state assignment no. 0352-2019-0011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. Before sampling the material (peripheral whole blood), the women gave their voluntary, written, informed consent to participate in the study. The study was conducted confidentially and in accordance with the ethical standards of the 1975 Declaration of Helsinki.
Additional information
Translated by K. Lazarev
Rights and permissions
About this article
Cite this article
Gordeeva, L.A., Mun, S.A., Voronina, E.N. et al. Association between Cytokine Gene Polymorphisms and Breast Cancer in Postmenopausal Women. Adv Gerontol 11, 44–52 (2021). https://doi.org/10.1134/S2079057021010367
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057021010367